🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label Phase II study to determine the rate of improvement i...
Status
Completed
Location
University of Maryland Medical Center - M & S Greenebaum Cancer Center
Start Date
2010-11
Trial ID
NCT01242930
Treatments Being Tested
This study will determine the safety and effectiveness of AMG 706 in patien...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00089960
Treatments Being Tested
The purpose of this is to evaluate the efficacy and safety of imetelstat (G...
Status
Completed
Location
Achieve Clinical Research, Llc
Start Date
2010-05
Trial ID
NCT01137968
Treatments Being Tested
The purpose of this study is to determine the safety and the maximum tolera...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Start Date
2007-11
Trial ID
NCT00594126
Treatments Being Tested
The purpose of this study is to determine the best dose of imetelstat when ...
Status
Withdrawn
Location
CHU Sainte-Justine
Start Date
2013-07-30
Trial ID
NCT01916187
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00861419
The study involves the use of three different dosing regimens of AMG 706 in...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00448786
The purpose of this study is to determine the safety and the maximum tolera...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2007-07
Trial ID
NCT00510445
Treatments Being Tested
RATIONALE: AMG 706 may stop the growth of tumor cells by blocking some of t...
Status
Terminated
Location
Providence Saint Joseph Medical Center - Burbank
Start Date
2007-12
Trial ID
NCT00574951
Treatments Being Tested
This is a phase II open-label study of single agent imetelstat in patients ...
Status
Completed
Location
City of Hope
Start Date
2010-12
Trial ID
NCT01243073
Treatments Being Tested